Macro Insights - The Caixin China Manufacturing PMI fell to 48.3 in May, marking the first contraction since October of the previous year, with production and new orders both dropping to their lowest levels since December 2022 and October 2022 respectively [3] - The OECD has revised down its global GDP growth forecast for 2025 to 2.9%, previously at 3.1%, and also lowered the 2026 forecast from 3.0% to 2.9% [4] Bond Market Insights - In May, the issuance of ETFs experienced a decline for the fourth consecutive month, with only 11.068 billion units issued, the lowest in five months, while bond funds dominated the market with a 55.07% share [6] Corporate Alerts - Longshan City Investment announced that its chairman is under investigation for serious violations of discipline and law [7] - The Shaanxi Xixian New Area Development Group has 70.399 billion yuan in restricted assets, accounting for 88.87% of its net assets, with overdue financing amounts reaching 443 million yuan [8] - Shenzhen Longguang Holdings announced that its restructuring and grace period proposals were not approved, with total debts of 27.8532 billion yuan as of April 30, 2025 [9] - The Qinhan New City project has generated only 8.1 million yuan in revenue against an expected 260.2 million yuan due to macroeconomic slowdown [10] - Wenzhou Public Utilities Group reported an increase in borrowings of 3.824 billion yuan, representing 29.52% of its net assets as of the end of the previous year [11] Stock Market Insights - The Shenzhen Component Index and ChiNext Index will undergo sample adjustments, effective June 16, with multiple stocks being added [13] - NIO reported a Q1 2025 adjusted net loss of 6.279 billion yuan, compared to a net loss of 4.903 billion yuan in the same period last year [15] Industry Alerts - The Ministry of Commerce responded to the EU's proposed restrictions on Chinese companies participating in public procurement for medical devices, condemning it as a discriminatory measure [36] - The National Federation of Industry and Commerce's automotive dealers' association called for a resistance against "involutionary" competition, particularly price wars [37] - The domestic refined oil prices have increased for the fourth time this year, with gasoline and diesel prices rising by 65 yuan and 60 yuan per ton respectively [39] - The China Coal Transportation and Marketing Association reported weak coal consumption since April, with high inventory levels and declining prices [40]

证券代码：002201 证券简称：九鼎新材 公告编号：2025-31 江苏九鼎新材料股份有限公司 关于收到辽宁省沈阳市中级人民法院通知书及执行裁定书 暨 5%以上股东所持部分股份将被司法拍卖的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别风险提示： 1、江苏九鼎新材料股份有限公司（以下简称"公司"或"本公司"）收到辽宁省沈阳 市中级人民法院（以下简称"沈阳中院"）（2024）辽01执2902号《通知书》并附两份《执 行裁定书》，裁定变卖西安正威新材料有限公司（以下简称"西安正威"）持有的公司 41,320,000股股票，其中8,320,000股股票分13个包予以拍卖变价处置，将于2025年6月29 日-30日在京东网进行第一次网络司法拍卖。 2、公司通过京东司法拍卖平台（网址：http://sifa.jd.com/）获悉，公司5%以上股 东西安正威持有的本公司8,320,000股无限售流通股份将被沈阳中院分13个包通过京东司法 拍卖平台拍卖。 3、本次拟拍卖标的物为西安正威持有的公司8,320,000股无限售流通股，占其持有本 公司股份总数4 ...

国浩律师（上海）事务所 见证法律意见书 上海市静安区山西北路 99 号苏河湾中心 MT25-28 楼 邮编:200085 25-28/F, Suhe Centre, 99 North Shanxi Road, Jing'an District, Shanghai, China T. +86 21 52341668 F. +86 21 52341670 E. grandallsh@grandall.com.cn W. www.grandall.com.cn 2025 年 5 月 关 于 江苏九鼎新材料股份有限公司 2024 年年度股东大会 的 国浩律师（上海）事务所 法律意见书 国浩律师（上海）事务所 关于江苏九鼎新材料股份有限公司 2024 年年度股东大会之见证法律意见书 致：江苏九鼎新材料股份有限公司 江苏九鼎新材料股份有限公司（以下简称"公司"）2024 年年度股东大会于 2025 年 5 月 15 日 14 时 00 分在江苏省如皋市中山东路 1 号公司会议室召开，国 浩律师（上海）事务所（以下简称"本所"）接受公司的委托，指派秦桂森律师、 黄雨桑律师（以下简称"本所律师"）出席会议，并依据《中华人民共 ...

证券代码：002201 证券简称：九鼎新材 公告编号：2025-30 江苏九鼎新材料股份有限公司 2024 年度股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会未出现否决议案的情形。 2、本次股东大会未涉及变更前次股东大会决议。 一、会议召开的情况 1、会议召开时间： 现场会议时间：2025 年 5 月 15 日 14:00 网络投票时间：2025 年 5 月 15 日 其中：通过深圳证券交易所交易系统进行网络投票的具体时间为 2025 年 5 月 15 日 9:15 至 9:25，9:30 至 11:30，13:00 至 15:00；通过深圳证券交易所互联网投票的具体时 间为 2025 年 5 月 15 日 9:15 至 15:00 期间的任意时间。 2、现场会议召开地点：江苏省如皋市中山东路 1 号公司会议室 3、会议召开方式：现场投票和网络投票相结合的方式 4、会议召集人：公司第十一届董事会 5、会议主持人：公司董事长顾清波先生 出席会议的中小股东（中小股东是指以下股东以外的其他股东：1、上市公司的董事、 监 ...

Core Viewpoint - The national key laboratories in China play a crucial role in promoting technological innovation and economic development, with over 270 established by 2024, covering multiple disciplines and contributing to talent cultivation and academic exchange [1][15][16]. Industry Overview - National key laboratories are essential components of the national scientific innovation system, focusing on high-level basic and applied research, talent cultivation, and advanced scientific equipment [3]. - There are three main types of national key laboratories: those focused on theoretical research, applied basic research, and engineering science research [4]. Development History - The construction of national key laboratories began in 1984, with 155 established by 1997, followed by a period of standardization and improvement from 1998 to 2007, and a significant increase in funding and development since 2008 [7][8]. Industry Chain - The industry chain for national key laboratory construction includes upstream suppliers of laboratory furniture and materials, midstream service providers, and downstream clients across various sectors such as manufacturing, agriculture, medicine, and energy [9][11]. Development Environment - The policy framework for technological innovation in China has strengthened, leading to increased R&D funding from CNY 14,169.88 billion in 2015 to CNY 36,130 billion in 2024, with a compound annual growth rate of 10.96% [13]. Current Industry Status - The national key laboratory system has achieved significant results, with a focus on structural reform and functional reorganization to enhance innovation efficiency and service capabilities [15][16]. Key Enterprises - The industry is characterized by a large number of small-scale enterprises with varying technical capabilities, with notable companies including Panmei Lab, Kebe Technology, and Laibotai Technology [19][20]. Future Trends - The industry is expected to see deep interdisciplinary integration, intelligent transformation through AI and IoT, and a focus on sustainable development in line with carbon neutrality goals [25][26][28].

Financial Performance - The company's operating revenue for Q1 2025 was ¥292,926,424.50, representing a 6.98% increase compared to ¥273,813,752.28 in the same period last year[5]. - Net profit attributable to shareholders increased by 84.89% to ¥16,436,383.22 from ¥8,889,745.44 year-on-year[5]. - The net profit after deducting non-recurring gains and losses rose by 112.64% to ¥13,270,272.65 compared to ¥6,240,793.39 in the previous year[5]. - The basic earnings per share increased by 85.29% to ¥0.0252 from ¥0.0136 in the same period last year[5]. - Operating profit increased to ¥20,342,611.43, compared to ¥17,498,607.74, marking a growth of 10.5%[21]. - Net profit for the current period was ¥16,436,383.22, representing a significant increase of 85.5% from ¥8,889,745.44 in the previous period[22]. - Earnings per share (EPS) for the current period was ¥0.0252, up from ¥0.0136 in the previous period, indicating a 85.3% increase[22]. Cash Flow - The net cash flow from operating activities decreased by 32.31% to ¥1,652,847.04 from ¥2,441,908.76 year-on-year[5]. - Cash inflow from operating activities totaled ¥246,592,612.11, compared to ¥217,490,747.94 in the previous period, reflecting an increase of 13.4%[23]. - Cash outflow from operating activities totaled $244,939,765.07, an increase from $215,048,839.18 in the previous period[24]. - Cash inflow from financing activities increased to $69,800,000.00 from $50,000,000.00 in the previous period[24]. - Net cash flow from financing activities improved to $57,268,267.68 from a negative -$48,851,640.36 year-over-year[24]. - The net increase in cash and cash equivalents was $4,196,847.21, recovering from a decrease of -$37,300,733.58 in the prior period[24]. - The ending balance of cash and cash equivalents was $79,908,627.27, down from $106,587,356.72 year-over-year[24]. Assets and Liabilities - Total assets at the end of the reporting period were ¥2,673,408,710.99, a decrease of 0.73% from ¥2,693,162,444.94 at the end of the previous year[5]. - The total liabilities decreased to ¥1,559,396,074.03 from ¥1,595,586,191.20, a reduction of approximately 2.3%[18]. - The company's total liabilities increased, with accounts receivable rising by ¥187,700 and prepaid accounts increasing by ¥22,914,200[8]. - Current assets decreased from CNY 1,509,378,395.84 to CNY 1,494,803,805.44, reflecting a decline of about 0.97%[16]. - Accounts receivable decreased from CNY 566,067,517.14 to CNY 479,860,901.13, a decrease of approximately 15.25%[16]. - Inventory increased from CNY 458,351,966.60 to CNY 544,796,763.82, representing an increase of about 18.86%[16]. - Short-term borrowings increased from CNY 424,574,205.81 to CNY 494,426,197.81, an increase of approximately 16.43%[17]. - Accounts payable decreased from CNY 714,182,658.73 to CNY 633,541,092.37, a decrease of about 11.29%[17]. - The company’s long-term equity investments decreased from CNY 36,277,259.05 to CNY 35,187,812.10, a decline of approximately 3.01%[17]. - The company’s non-current assets totaled CNY 1,178,604,905.55, slightly down from CNY 1,183,784,049.10, a decrease of about 0.43%[17]. Expenses - Total operating costs amounted to ¥269,697,308.97, up from ¥258,012,141.00, reflecting a rise of 4.5%[21]. - Research and development expenses were ¥13,147,324.48, slightly down from ¥14,064,228.11, indicating a decrease of 6.5%[21]. - The company experienced a 39.02% increase in taxes and surcharges, amounting to an increase of ¥1,330,200 compared to the same period last year[9]. - Selling expenses rose by 34.52%, increasing by ¥2,218,400 year-on-year, primarily due to higher travel and salary costs for sales personnel[9]. - The company reported a tax expense of ¥6,228,488.31, down from ¥10,462,995.18, a decrease of 40.5%[21]. Strategic Developments - The company has signed a contract change agreement with related parties, indicating ongoing strategic partnerships[15]. - The company’s first quarter report was not audited[26].

Group 1 - Multiple companies, including Tangde Film and Television, Rhine Sports, Zhengwei New Materials, and Ruipu Biology, announced name changes to align with their strategic transformations in 2025 [1][2][3] - Tangde Film and Television will change its name to Zhejiang Huazhi Digital Media Co., Ltd. on April 25, 2025, to better reflect its future development direction and enhance brand recognition [1] - Rhine Sports changed its name to Chengdu Xintiandi Cultural Tourism Development Co., Ltd. to better align with its business characteristics and strategic positioning [2] Group 2 - Jinmao Yinniao announced a name change to Mount Everest Gold Group Company Limited, reflecting its focus on the jewelry new retail business, which contributed over 97% of its revenue for the six months ending June 30, 2024 [2][3] - Ruipu Biology changed its name to Ruipu Biological Co., Ltd. to better suit its expanded business scope and enhance its brand image, having established a significant presence with over 20 subsidiaries and 100 new veterinary drug registrations [3] - AVIC Electromechanical changed its name to AVIC Chengfei after completing a major asset restructuring, with Chengfei becoming its wholly-owned subsidiary [3]

江苏九鼎新材料股份有限公司 2025年第一次独立董事专门会议审核意见 根据《上市公司独立董事管理办法》《深圳证券交易所股票上市规则》《深圳证券交 易所上市公司自律监管指引第1号——主板上市公司规范运作》《江苏九鼎新材料股份有限 公司独立董事制度》等有关规定，江苏九鼎新材料股份有限公司（以下简称"公司"）于 2025年4月7日以现场表决方式召开了2025年第一次独立董事专门会议，对公司第十一届董 事会第二次会议相关议案进行审议，并发表如下审核意见： 一、《关于公司2025年日常关联交易预计的议案》 1、本次交易为公司的日常关联交易； 2、本次关联交易采用等价有偿、公允市价的定价原则，价格以公开、公平、公正、公 允为原则，符合法律法规的规定和市场规律，不存在损害公司利益的情况； 3、同意将《关于公司2025年日常关联交易预计的议案》提交公司第十一届董事会第二 次会议审议。 2、本次关联交易定价以市场价格为定价依据，属于正常的商业行为，符合法律法规的 规定和市场规律，不存在利用关联交易向关联方输送利益的情形，不存在损害公司及非关 联股东特别是中小投资者利益的情况； 3、同意将《关于全资孙公司向关联方采购设备暨关联交 ...

（一）个人情况 本人姜林，1975 年 11 月出生，法学硕士。现任上海市联合律师事务所 高级合伙人、执业律师，兼任上海现代服务业联合会低碳经济服务专业委员 会副秘书长、上海杉树公益基金会监事长、上海现代服务业标准创新发展中 心监事、张家港富瑞特种装备股份有限公司独立董事。 江苏九鼎新材料股份有限公司 独立董事述职报告 各位股东及股东代表： 本人姜林，作为江苏九鼎新材料股份有限公司（以下简称："公司"）独 立董事，按照《公司法》《证券法》《上市公司独立董事管理办法》等相关法 律法规、规范性文件及《公司章程》、《公司独立董事工作制度》等规定，忠 实、勤勉、独立地履行独立董事职责，积极出席 2024 年度相关会议，认真审 议会议各项议案，充分发挥独立董事的独立作用，切实维护公司和全体股东 尤其是中小股东的合法权益。 作为公司独立董事，从法学专业角度给予公司建议，强调上市公司治理 应当健全、有效、透明，尊重利益相关者的基本权益，保障股东的合法权利 并确保其得到公平对待，积极履行社会责任，切实提升企业整体价值。一方 面及时关注中国证券监督管理委员会、深圳证券交易所等关于上市公司、独 立董事方面的公告及法规，另一方面积 ...

江苏九鼎新材料股份有限公司 独立董事述职报告 各位股东及股东代表： 本人朱鉴，作为江苏九鼎新材料股份有限公司（以下简称"公司"）独立 董事，按照《公司法》《证券法》《上市公司独立董事管理办法》等相关法律 法规、规范性文件及《公司章程》《公司独立董事工作制度》等规定，忠实、 勤勉、独立地履行独立董事职责，积极出席 2024 年度相关会议，认真审议 会议各项议案，充分发挥独立董事的独立作用，切实维护公司和全体股东尤 其是中小股东的合法权益。 本人于2024年担任公司第十届董事会独立董事、审计委员会主任委员、 提名委员会委员、薪酬与考核委员会委员职务，公司于 2024 年 11 月 25 日 召开 2024 年第三次临时股东大会选出第十一届董事会独立董事后，本人正 式离任。根据相关要求，现将 2024 年度本人履行职责情况述职如下： 一、独立董事基本情况 （一）个人情况 本人朱鉴，1963 年 7 月出生，本科学历，中共党员，注册会计师、资产 评估师、造价工程师。曾任北京市城建四公司组织干事、北京市审计局干部、 江苏如皋审计事务所所长。现任如皋皋审会计师事务所所长、主任会计师, 兼任南通皋审工程项目管理有限公司执行 ...